Skip to content
Open access

Structure-signal relationships at κ-opioid receptor (KOR) revealed by bicyclo[2.2.2]octene enamide derivatives.

Oct 2026 · European journal of medicinal chemistry · Vol 321 Pt 3, pp. 119464 · 0 citations · 45 references
Medicine

Abstract

κ-Opioid receptor (KOR) agonists are promising candidates for analgesic development, yet their clinical application is limited by on-target adverse effects such as sedation and dysphoria. Attenuating β-arrestin2 recruitment while retaining G-protein signaling has therefore attracted interest as a strategy for improving KOR agonist pharmacology. However, how subtle ligand structural changes alter receptor interactions and signaling outcomes remains incompletely understood. Here, we synthesized a series of bicyclo[2.2.2]octene enamide derivatives and examined their structure-signal relationships by systematically varying linker length and amide N-substitution. Functional characterization showed that these derivatives retained robust Gi protein activation (Emax = 80.4-103% relative to dynorphin A) while exhibiting attenuated β-arrestin2 recruitment (Emax = 12.6-61.8%). Notably, within the NH series, β-arrestin2 efficacy did not scale uniformly with linker length, whereas N-methylation did not produce a consistent effect across matched analogues. Induced-fit docking showed similar static binding poses among the NH derivatives despite their distinct β-arrestin2 efficacies. Molecular dynamics simulations, in contrast, revealed differences in dynamic ligand-receptor interactions and ligand positioning within the TM2-TM3 region, particularly involving Q1152.60, D1383.32, Y1393.33, and Y3207.43. These findings suggest that KOR signaling outcomes are associated not simply with ligand occupancy of the TM2-TM3 region but also with the specific dynamic interactions and positioning established within this region. Our results provide a structural framework for understanding how subtle ligand modifications can produce distinct KOR signaling profiles.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.